Legislation watch

Search all years.

2017 Senate Bill 492: Impose oral chemotherapy insurance mandate
Introduced by Sen. Goeff Hansen (R) on June 22, 2017
To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments. Also, to prohibit an insurer from requiring a copayment greater than $100 for a 30 day supply of the pills.   Official Text and Analysis.
Referred to the Senate Insurance Committee on June 22, 2017
Reported in the Senate on October 12, 2017
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Received in the House on October 18, 2017
Referred to the House Insurance Committee on October 18, 2017
Reported in the House on June 7, 2018
With the recommendation that the bill be referred to the Committee on Health Policy.
Referred to the House Health Policy Committee on June 7, 2018